NettetEarnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants. Johnson & Johnson EPS for the quarter ending December 31, 2024 was $1.32, a 25.42% decline year-over-year. NettetGameStop Moderna Pfizer Johnson & Johnson AstraZeneca Walgreens Best Buy Novavax SpaceX Tesla. ... YOLO Rehab's market recap 4/11/2024 - Analysts lowering SP500 earnings estimate again, hedge funds most short since August 2024 . ... TLT leap call spread 110/115
Johnson & Johnson (JNJ) Q1 2024 Results - Earnings Call Transcript
Nettet19. jul. 2024 · Company maintaining 2024 full-year guidance at midpoints for adjusted operational sales and adjusted operational earnings per share; strengthening U.S. … NettetThe Investor Relations website contains information about Johnson & Johnson's business for stockholders, potential investors, and financial analysts. Skip to main … golding service borden
Webcasts & Presentations Johnson & Johnson
Nettet24. jan. 2024 · Analyst Recommendations on JOHNSON & JOHNSON. 03/29. UBS Adjusts Johnson & Johnson Price Target to $164 From $175, Maintains Neutral Rating. MT. 03/01. Guggenheim Initiates Johnson & Johnson at Neutral With $161 Price Target. MT. 01/25. Morgan Stanley Adjusts Price Target on Johnson & Johnson to $180 From … Nettet18. okt. 2024 · Reported sales growth of 1.9% to $23.8 Billion with operational growth of 8.1%* and adjusted operational growth of 8.2%*Earnings per share (EPS) of $1.68 … Nettet19. okt. 2024 · Johnson & Johnson Reports Q3 2024 Results. Total sales growth of 10.7% to $23.3 Billion with operational growth of 9.9%* and adjusted operational growth of 10.6%*. Earnings per share of $1.37 increasing 3.0% and adjusted earnings per share of $2.60 increasing 18.2%*. Company increasing 2024 Full-Year Guidance. headed shear stud reinforcement